Assyro AI

FDA Orange Book · active-ingredient family

Fluoxymesterone

Fluoxymesterone is approved as 2 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:HALOTESTIN · NDA 010611

2

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
HALOTESTIN×3PHARMACIA AND UPJOHNNDA 010611Approved Prior to Jan 1, 1982
ORA-TESTRYL×2BRISTOL MYERS SQUIBBNDA 011359Approved Prior to Jan 1, 1982

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
FLUOXYMESTERONEWATSON LABSANDA 088260Dec 06, 1983
FLUOXYMESTERONEWATSON LABSANDA 088265Dec 06, 1983
FLUOXYMESTERONEWATSON LABSANDA 088309Dec 06, 1983
FLUOXYMESTERONEUPSHER SMITH LABSANDA 088342Oct 21, 1983
FLUOXYMESTERONEVALEANT PHARM INTLANDA 088221May 05, 1983
ANDROID-FVALEANT PHARM INTLANDA 087196Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Fluoxymesterone — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.